ACT 831/2025

—·EP2196231: System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Case details: Status
—
Action
Application for costs
Category
Costs Assessments
Parties: Claimants
Roche Diabetes Care GmbH
Reps: Christof Augenstein (Kather Augenstein); Katharina Brandt (Kather Augenstein); Robert Knaps (Kather Augenstein); Thomas Kronberger (Grünecker Patent- und Rechtsanwälte PartGmbH)
Respondents
Tandem Diabetes Care, Inc.
Tandem Diabetes Care Europe B.V.
Reps: Charlotte Garnitsch (Taylor Wessing); Wim Maas (Taylor Wessing); Alexander Rubusch (Taylor Wessing)
Division: Paris CD
Judges: Paolo Catallozzi · Presiding judge and judge-rapporteur
Tatyana Zhilova · Legally qualified judge
Giorgio Checcacci · Technically qualified judge
Technology: Pharmaceutical & Medical
Language: —
First decided: Apr 29, 2025

Decisions

2025-04-29
Costs onlyCostsApplication For Costs
The Central Division Paris issued a costs order in connection with the revocation action UPC_CFI_454/2023, requiring Tandem Diabetes to pay Roche Diabetes Care's representation and litigation costs. The Court rejected Tandem Diabetes's request to stay the costs proceedings pending the appeal against the decision on the merits.
Legal issues:Costs decisionStay of costs proceedingsPending appeal against merits decisionReimbursable representation costs ceilingArt. 69 UPCA
2025-04-29
Costs onlyCostsApplication For Costs
The Paris Central Division issued a cost decision ordering Tandem Diabetes Care to pay Roche Diabetes Care's legal costs of EUR 112,000 plus travel expenses and court fees totalling approximately EUR 119,623, following Roche's success in the underlying revocation action.
Legal issues:Cost decision (Art. 69 UPCA)Stay of cost proceedings pending appealReimbursement of travel expenses for in-house representatives

Documents